Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for CRSsNP
NCT04362501Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2020
- Primary completion
- Sep 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in chronic rhinosinusitis without nasal polyps (CRSsNP), sponsored by Johns Hopkins University. Started Oct 2020; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis without nasal polyps (CRSsNP)
Beyond the preview
Go deeper on NCT04362501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04362501.